XRT secures new investors

By Helen Schuller
Monday, 29 August, 2005

Unlisted imaging company XRT, an investee of BioTech Capital (ASX:BTC), has secured new investment funds from a syndicate of UK investors including an undisclosed institutional group.

Total funds to be invested in XRT equate to approximately £1.5 million (AUD$3.8million) at a pre-money valuation of £7.1 million.

Melbourne based XRT is planning to relocate its business development activities to the UK and will use the funds for the recruitment of a UK-based senior management team and to execute its business plan.

Content from other channels on our network

Indigenous food culture and responsible seafood celebrated

Shaking up whey protein manufacturing technique

Danone to acquire Made Group

Five trends tracked for NZ's fresh produce sector

Poultry and egg producers in lockdown as avian flu detected in WA

Partnership to develop lower-emission titanium production

Refinery transforms CO2 into useable raw materials

Siemens expands Fusesaver manufacturing facility

BESS project provides long-duration battery for NSW

Lessons in long-distance telemetry

The Data-Ready Foundation for an AI-Powered Healthcare Future

Innovating chemical dosing & dilution in aged care

A shift in clinical practice: optimal antibiotics for golden staph bloodstream infections

The rise of non-clinical, community-led safe spaces: how lived experience is reshaping suicide prevention

Mandatory VR violence training for nursing students

XRT secures new investors

AusBiotech partners with Tenmile

Australian CDC issues update in wake of Ebola outbreak

Australia announces $7.2m diphtheria outbreak response package

Content from other channels on our network